BioCentury
ARTICLE | Company News

Cygnus Therapeutic Systems deal

November 1, 1993 8:00 AM UTC

CYGN and Procter & Gamble will develop and market an undisclosed consumer product using a CYGN delivery system. Under the agreement Procter & Gamble gets worldwide marketing rights and CYGN will receive royalties and a manufacturing margin. CYGN said it anticipates royalty income from the product, which is in test marketing, by 1996. ...